CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

/content/bmj/340/bmj.c869/F2.large.jpg?

Overestimation of Late Distant Recurrences in High-Risk Patients

PDF) Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial, Breast Cancer Research

Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results, BMC Cancer

Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative - European Journal of Cancer

CONSORT 2010 explanation and elaboration: Updated guidelines for

Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials - ScienceDirect

Louis FEHRENBACHER, Medical Director, Kaiser Permanente Oncology Clinical Trials KPNC, Oncology

Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study, Radiation Oncology